Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b066ac7ed6c9ecd5e86088561b49169b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
filingDate |
2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccfce349d45ba66665a758d5ab0e8807 |
publicationDate |
2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2523659-T3 |
titleOfInvention |
Compositions and procedures for the treatment of cardiovascular diseases |
abstract |
Use of one or more vasoactive intestinal peptide (VIP) and / or active fragment (s) thereof for the preparation of a medicament for the therapeutic or prophylactic treatment of myocardial fibrosis in a subject, in which the active fragment It is VIP (1-12) and / or VIP (6-28). |
priorityDate |
2004-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |